Self-Administered Flu Vaccine May Be Available Next Year, AstraZeneca Says
The U.S. Food and Drug Administration has accepted for review AstraZeneca’s Supplemental Biologics License Application (sBLA) to approve its self- or caregiver-administered option for a needle-free nasal spray flu vaccine, the...To view the full article, register now.
Already a subscriber? Click here to view full article